Skip to main content
. 2015 Jul 31;1:2055217315596994. doi: 10.1177/2055217315596994

Figure 2.

Figure 2.

Older age, lower baseline ALC and recent natalizumab exposure are risk factors for DMF-induced lymphopenia. Kaplan Meier analyses were used to model the cumulative incidence of DMF-induced grade 3 (a)–(d) or combined grade 2 + 3 (e)–(h) lymphopenia. P values represent the log rank test for differences between groups. DMF: dimethyl fumarate; ALC: absolute lymphocyte count; DMT: disease-modifying therapy. Quartile 1 ALC: 200–1380, quartile 2: 1381–1815; quartile 3: 1816–2400; quartile 4: 2401–5000.